# Cognitive Impairment and Affective Mood Disorders in Patients With IBD

> **NCT05760729** · — · UNKNOWN · sponsor: **Iuliu Hatieganu University of Medicine and Pharmacy** · enrollment: 75 (estimated)

## Conditions studied

- Inflammatory Bowel Diseases
- Mild Cognitive Impairment
- Depression
- Anxiety
- Stress
- Quality of Life

## Interventions

- **DIAGNOSTIC_TEST:** Cognitive testing

## Key facts

- **NCT ID:** NCT05760729
- **Lead sponsor:** Iuliu Hatieganu University of Medicine and Pharmacy
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-05-30
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2023-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05760729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05760729, "Cognitive Impairment and Affective Mood Disorders in Patients With IBD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05760729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*